KinasePro

Kinase Chemistry – Just a year and a half behind the times.

Archive for July 18th, 2007

Correction

Posted by kinasepro on July 18, 2007

Pfizer’s Jak3 inhibitor CP-690,550 was described earlier listed as Ph ii-iii. For some reason that was changed, and all of its furthest advanced trials are Phase 2.

Advertisements

Posted in JAK, Phase III | 1 Comment »